Diabetes and diabetic polyneuropathies: the role of B group vitamins
- Authors: Kotova O.V.1,2, Akarachkova E.S.2,3, Belyaev A.A.4
-
Affiliations:
- Medical Institute of Peoples' Friendship University of Russia
- International Society «Stress under control»
- Rehaline Rehabilitation Center
- N.B. Sklifosovsky Research Institute of Emergency Medicine of the Department of Healthcare of Moscow
- Issue: Vol 7, No 4 (2021)
- Pages: 147-154
- Section: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/288236
- DOI: https://doi.org/10.18565/therapy.2021.4.147-154
- ID: 288236
Cite item
Abstract
Full Text
About the authors
Olga V. Kotova
Medical Institute of Peoples' Friendship University of Russia; International Society «Stress under control»
Email: ol_kotova@mail.ru
PhD, neurologist, psychiatrist, associate professor of the Department of psychiatry, psychotherapy and psychosomatic pathology of Faculty of continuous medical education; vice-president 117198, Moscow, 21/3 Miklukho-Maklaya Ste
Elena S. Akarachkova
International Society «Stress under control»; Rehaline Rehabilitation CenterMD, neurologist, president 115573, Moscow, 40 Musy Jalilya Str
Anton A. Belyaev
N.B. Sklifosovsky Research Institute of Emergency Medicine of the Department of Healthcare of Moscowjunior researcher of the Department of emergency vascular surgery 129090, Moscow, 3/1 Bolshaya Sukharevskaya Sq
References
- United Nations, Department of Economic and Social Affairs, Population Division (2019). World Population Ageing 2019: Highlights (ST/ESA/SER.A/430). URL: https://www.google.com.sg/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjI_u_GqPLpAhXBSH0KHdNgBcQQFjAAegQIBBAB&url=https%3A%2F%2Fwww.un.org%2Fen%2Fdevelopment%2Fdesa%2Fpopulation%2Fpublications%2Fpdf%2Fageing%2FWorldPopulationAgeing2019-Highlights.pdf&usg=AOvVaw0C2HroVeVv_ijqlZBxbVhS (date of access - 02.06.2020).
- World Health Organization. Diabetes. URL: https://www.who.int/health-topics/diabetes#tab=tab_2 (date of access -02.06.2020).
- Volmer-Thole M., Lobmann R. Neuropathy and diabetic foot syndrome. Int J Mol Sci. 2016; 17(6): 917. doi: 10.3390/ijms17060917.
- Said G. Diabetic neuropathy. Handb Clin Neurol. 2013; 115: 579-89. doi: 10.1016/B978-0-444-52902-2.00033-3.
- Ziegler D., Keller J., Maier C., Pannek J. Diabetic neuropathy. Exp Clin Endocrinol Diabetes. 2014; 122(7): 406-15. doi: 10.1055/s-0034-1366435.
- Котова О.В., Акарачкова Е.С. Диабетическая автономная полиневропатия. Журнал неврологии и психиатрии им. C.C. Корсакова. 2017; 2: 169-173. doi: https://doi.org/10.17116/jnevro201711721169-173.
- Balcioglu A.S., Muderrisoglu H. Diabetes and cardiac autonomic neuropathy: clinical manifestations, cardiovascular consequences, diagnosis and treatment. World J Diabetes. 2015; 6(1): 80-91. doi: 10.4239/wjd.v6.i1.80.
- Spallone V., Ziegler D., Freeman R. et al. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. 2011; 27(7): 639-53. doi: 10.1002/dmrr.1239.
- Vinik A.I., Freeman R., Erbas T. Diabetic autonomic neuropathy. Semin Neurol. 2003; 23(4): 365-72. doi: 10.1055/s-2004-817720.
- Pop-Busui R. What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes. J Cardiovasc Transl Res. 2012; 5(4): 463-78. doi: 10.1007/s12265-012-9367-6.
- Dimitropoulos G., Tahrani A.A., Stevens M.J. Cardiac autonomic neuropathy in patients with diabetes mellitus. World J Diabetes. 2014; 5(1): 17-39. doi: 10.4239/wjd.v5.i1.17.
- Hillis G., Woodward M., Rodgers A. et al. Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus. Diabetologia. 2012; 55(5): 1283-90. doi: 10.1007/s00125-012-2471-y.
- Vinik A.I., Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007; 1 15(3): 387-97. doi: 10.1161/CIRCULATIONAHA.106.634949.
- Kuehl M., Stevens M.J. Cardiovascular autonomic neuropathies as complications of diabetes mellitus. Nat Rev Endocrinol. 2012; 8(7): 405-16. doi: 10.1038/nrendo.2012.21.
- Ninkovic V.M., Ninkovic S.M., Miloradovic V. et al. Prevalence and risk factors for prolonged QT interval and QT dispersion in patients with type 2 diabetes. Acta Diabetol. 2016; 53(5): 737-44. doi: 10.1007/s00592-016-0864-y.
- Беляев А.А., Котова О.В., Акарачкова Е.С. Кардиальная автономная невропатия у больных сахарным диабетом. Медицинский совет. 2019; 1: 52-56. doi: https://doi.org/10.21518/2079-701X-2019-1-52-56.
- Huang I., Lim M.A., Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - a systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 2020; 14(4): 395-403. doi: 10.1016/j.dsx.2020.04.018.
- Kumar A., Arora A., Sharma P. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab Syndr. 2020; 14(4): 535-45. doi: 10.1016/j.dsx.2020.04.044.
- Cariou B., Hadjadj S., Wargny M. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020; 63(8): 1500-15. doi: 10.1007/s00125-020-05180-x.
- Dongarwar D., Salihu H.M. COVID-19 Pandemic: marked global disparities in fatalities according to geographic location and universal health care. Int J MCH and AIDS. 2020; 9(2): 213-16. doi: 10.21106/ijma.389.
- Fauci A.S., Lane H.C., Redfield R.R. Covid-19 - navigating the uncharted. N Engl J Med. 2020; 382(13): 1268-69. doi: 10.1056/NEJMe2002387.
- Gupta R., Hussain A., Misra A. Diabetes and COVID-19: evidence, current status and unanswered research questions. Eur J Clin Nutr. 2020; 74(6): 864-70. doi: 10.1038/s41430-020-0652-1.
- Verdecchia P., Cavallini C., Spanevello A., Angeli F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med. 2020; 76: 14-20. doi: 10.1016/j.ejim.2020.04.037.
- Bousquet J., Anto J.M., Iaccarino G. Is diet partly responsible for differences in COVID-19 death rates between and within countries? Clin Transl Allergy. 2020; 10: 16. doi: 10.1186/s13601-020-00323-0.
- Calder P.C., Carr A.C., Gombart A.F., Eggersdorfer M. Optimal nutritional status for a well-functioning immune system is an important factor to protect against viral infections. Nutrients. 2020; 12(4): 1181. doi: 10.3390/nu12041181.
- Gombart A.F., Pierre A., Maggini S. A review of micronutrients and the immune system-working in harmony to reduce the risk of infection. Nutrients. 2020; 12(1) :236. doi: 10.3390/nu12010236.
- Li T., Zhang Y., Gong C. Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China. Eur J Clin Nutr. 2020; 74(6): 871-75. doi: 10.1038/s41430-020-0642-3.
- NIH, U.S. National Library of Medicine. ClinicalTrails.gov. URL: https://clinicaltrials.gov/ct2/results?cond=COVID&term=vitamin&cntry=&state=&city=&dist= (date of access - 02.06.2020).
- Stabler S.P., Allen R.H. Vitamin B12 deficiency as a worldwide problem. Annu Rev Nutr. 2004; 24: 299-326. doi: 10.1146/annurev.nutr.24.012003.132440.
- Laird E.J., O'Halloran A.M., Carey D. et al. Voluntary fortification is ineffective to maintain the vitamin B12 and folate status of older Irish adults: evidence from the Irish Longitudinal Study on Ageing (TILDA). Br J Nutr. 2018; 120(1): 111-20. doi: 10.1017/S0007114518001356.
- Green R., Allen L.H., Bjorke-Monsen A.L. Vitamin B12 deficiency. Nat Rev Dis Primers. 2017; 3: 17040. doi: 10.1038/nrdp.2017.40.
- Hunt A., Harrington D., Robinson S. Vitamin B12 deficiency. BMJ. 2014; 349: g5226. doi: 10.1136/bmj.g5226.
- Pannerec A., Migliavacca E., De Castro A. Vitamin B12 deficiency and impaired expression of amnionless during aging. J Cachexia Sarcopenia Muscle. 2018; 9(1): 41-52. doi: 10.1002/jcsm.12260.
- De S., Kuwahara S., Saito A. The endocytic receptor megalin and its associated proteins in proximal tubule epithelial cells. Membranes (Basel). 2014; 4(3): 333-55. doi: 10.3390/membranes4030333.
- Pflipsen M.C., Oh R.C., Saguil A. et al. The prevalence of vitamin B(12) deficiency in patients with type 2 diabetes: a crosssectional study. J Am Board Fam Med. 2009; 22(5): 528-34. doi: 10.3122/jabfm.2009.05.090044.
- Beulens J.W., Hart H.E., Kuijs R. et al. Influence of duration and dose of metformin on cobalamin deficiency in type 2 diabetes patients using metformin. Acta Diabetol. 2015; 52(1): 47-53. doi: 10.1007/s00592-014-0597-8.
- Han Wee A.K. Serum folate predicts muscle strength: a pilot cross-sectional study of the association between serum vitamin levels and muscle strength and gait measures in patients >65 years old with diabetes mellitus in a primary care setting. Nutr J. 2016; 15(1): 89. doi: 10.1186/s12937-016-0208-3.
- Chamberlain J.J., Herman W.H., Leal S. et al. Pharmacologic therapy for type 2 diabetes: synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes. Ann Intern Med. 2017; 166(8): 572-78. doi: 10.7326/M16-2937.
- Aroda V.R., Edelstein S.L., Goldberg R.B. Long-term metformin use and vitamin B12 deficiency in the diabetes prevention program outcomes study. J Clin Endocrinol Metab. 2016; 101(4): 1754-61. doi: 10.1210/jc.2015-3754.
- Bauman W.A., Shaw S., Jayatilleke E. et al. Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin. Diabetes Care. 2000; 23(9): 1227-31. doi: 10.2337/diacare.23.9.1227.
- Stabler S.P. Clinical practice. Vitamin B12 deficiency. N Engl J Med. 2013; 368(2): 149-60. doi: 10.1056/NEJMcp11 13996.
- Ministry of Health, Singapore. Agency for Care Effectiveness (ACE) Appropriate Care Guide. Oral glucose-lowering agents in type 2 diabetes mellitus - an update. Version current 03 July 2017. URL: http://www.ace-hta.gov.sg/our-guidance/oral-glucose-lowering-agents-in-type-2-diabetes-mellitus-an-update.html (date of access - 27.03.2019).
- Tomkin G.H., Hadden D.R., Weaver J.A., Montgomery D.A. Vitamin-B12 status of patients on long-term metformin therapy. Br Med J. 1971; 2(5763): 685-87. doi: 10.1136/bmj.2.5763.685.
- Muhktar M., Sherry D., Keaver L., McHugh C.M. Metformin-induced B12 deficiency: still relevant today. Ir J Med Sci. 2020; 189(1): 409-10. doi: 10.1007/s11845-019-02070-z.
- Chamberlain J.J., Rhinehart A.S., Shaefer C.F. Jr, Neuman A. Diagnosis and management of diabetes: Synopsis of the 2016 American diabetes association standards of medical care in diabetes. Ann Intern Med. 2016; 164(8): 542-52. doi: 10.7326/M15-3016.
- Lam J.R., Schneider J.L., Zhao W., Corley D.A. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013; 310(22): 2435-42. doi: 10.1001/jama.2013.280490.
- Sun Y., Sun M., Liu B. Inverse association between serum vitamin B12 concentration and obesity among adults in the United States. Front Endocrinol (Lausanne). 2019; 10: 414. doi: 10.3389/fendo.2019.00414.
- Lind M.V., Lauritzen L., Vestergaard H. One-carbon metabolism markers are associated with cardiometabolic risk factors. Nutr Metab Cardiovasc Dis. 2018; 28(4): 402-10. doi: 10.1016/j.numecd.2018.01.005.
- Koplay M., Gulcan E., Ozkan F. Association between serum vitamin B12 levels and the degree of steatosis in patients with nonalcoholic fatty liver disease. J Investig Med. 2011; 59(7): 1 137-40. doi: 10.2310/JIM.0b013e31822a29f5.
- Cohen E., Margalit I., Shochat T. et al. Gender differences in homocysteine concentrations, a population-based crosssectional study. Nutr Metab Cardiovasc Dis. 2019; 29(1): 9-14. doi: 10.1016/j.numecd.2018.09.003.
- Kuch B., Bobak M., Fobker M. Associations between homocysteine and coagulation factors - a cross-sectional study in two populations of central Europe. Thromb Res. 2001; 103(4): 265-73. doi: 10.1016/s0049-3848(01)00321-8.
- Meng S., Ciment S., Jan M. Homocysteine induces inflammatory transcriptional signaling in monocytes. Front Biosci (Landmark Ed). 2013; 18: 685-95. doi: 10.2741/4131.
- Saeed F., Nadeem M., Ahmed R.S. et al. Studying the impact of nutritional immunology underlying the modulation of immune responses by nutritional compounds - a review. Food Agric Immunol. 2016; 27: 205-29.
- Tamura J., Kubota K., Murakami H. Immunomodulation by vitamin B12: augmentation of CD8+ T lymphocytes and natural killer (NK) cell activity in vitamin B12-deficient patients by methyl-B12 treatment. Clin Exp Immunol. 1999; 116(1): 28-32. doi: 10.1046/j.1365-2249.1999.00870.x.
- Котова О.В., Акарачкова Е.С., Беляев А.А. Неврологические осложнения сахарного диабета. Медицинский совет. 2019; 9: 40-44. doi: https://doi.org/10.21518/2079-701X-2019-9-40-44.
- Котова О.В. Диабетическая автономная полиневропатия. Фарматека. 2012; 6: 40-44.
- Беляев А.А., Котова А.А., Акарачкова Е.С. Боль в спине: использование витаминов группы В. Consilium Medicum. 2019; 9: 91-94. doi: https://dx.doi.org/10.26442/20751753.2019.9.190567.
- Wang H., Li L., Qin L.L. et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. Cochrane Database Syst Rev. 2018; 3(3): CD004655. doi: 10.1002/14651858.CD004655.pub3.
- Котова О.В. Диабетическая нейропатия. Применение нейротропных витаминов. Поликлиника. 2015; 1-2: 36-39